Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

41 Views

A4. Treatment of antimicrobial resistant infections

Poster Session: Treatment of Antimicrobial-Resistant Infections

(P-1310) Cefiderocol Remains Active against US Clinical Isolates of Stenotrophomonas maltophilia Non-susceptible to Comparator Agents: Results from the SENTRY Antimicrobial Surveillance Program (2020–2024)

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

SL

Salvatore Lentini, PharmD

Shionogi Inc
Brick, New Jersey, United States
SN

Sean T. Nguyen, PharmD

Director, Medical Affairs
Shionogi Inc.
Florham Park, NJ, United States
Boudewijn L. DeJonge, PhD

Director Microbiology
Shionogi Inc.
Florham Park, NJ, United States
JM

Joshua Maher, PhD

Element Materials Technology/Jones Microbiology Institute
North Liberty, Iowa, United States
Rodrigo E. Mendes, PhD (he/him/his)

Director
Element Iowa City (JMI Laboratories)
North Liberty, IA, United States
HY

Hidenori Yamashiro

subgroup leader
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan
Yoshinori Yamano, PhD (he/him/his)

Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan